Published on 20 Jun 2024 on Simply Wall St. · via Yahoo Finance
With 32% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a...
Key Insights
Nautilus Biotechnology's significant insider ownership suggests inherent interests in company's expansionA total of 4 investors have a majority stake in the company with 54% ownership 20% of Nautilus Biotechnology is held by Institutions
A look at the shareholders of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) can tell us which group is most powerful. We can see that individual insiders own the lion's share in the company with 32% ownership. Put another way, the group faces the maximum upside potential (or downside risk).